Concepedia

Publication | Open Access

Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19

DOIFull Paper Access

10

Citations

18

References

2022

Year

Jin Yeong Hong, Jae‐Hoon Ko, Jinyoung Yang, Soyoung Ha, Eliel Nham, Kyungmin Huh, Sun Young Cho, Cheol‐In Kang, Doo Ryeon Chung, Jin Yang Baek,
Yonsei Medical Journal

Abstract

A combination of severity-adjusted dexamethasone and tocilizumab for the treatment of severe COVID-19 improved clinical recovery without increasing infectious complications or hindering the immune response against SARS-CoV-2.

References

YearCitations

Page 1